-------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
-------------------------------------------------------------------------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report: November 20, 2003
Date of Earliest Event Reported: November 19, 2003
MILLENNIUM CHEMICALS INC.
(Exact name of registrant as specified in its charter)
Delaware 1-12091 22-3436215
(State or other jurisdiction of (I.R.S. Employer Identification Number)
incorporation or organization) (Commission File Number)
20 Wight Avenue, Suite 100
Hunt Valley, Maryland 21030
(Address of principal executive offices)
Registrant's telephone number, including area code (410) 229-4400
-------------------------------------------------------------------------------
Item 5. Other Events.
-------------
On November 19, 2003, Millennium Chemicals announced that it had
priced its offering of $125 million principal amount of 4%
convertible senior debentures due 2023, plus up to an additional
$25 million of debentures that may be issued at the option of the
initial purchasers. Millennium's November 19, 2003 press release
regarding the offering is being filed with this Current Report on
Form 8-K as Exhibit 99.1.
Item 7. Financial Statements and Exhibits.
----------------------------------
Exhibit Description
------- -----------
99.1 Press Release issued November 19, 2003
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on behalf of the undersigned
hereunto duly authorized.
Dated: November 20, 2003 MILLENNIUM CHEMICALS INC.
By:/C. William Carmean/
----------------------------------------
C. William Carmean
Senior Vice President, General Counsel &
Secretary
EXHIBIT INDEX
Exhibit Description
------- -----------
99.1 Press Release issued November 19, 2003